Outcomes of patients regimen allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Stem Cells Hematopoietic Stem Cells Antilymphocyte Serum T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Pluripotent Stem Cells Bone Marrow Cells Neural Stem Cells Mesenchymal Stromal Cells CD8-Positive T-Lymphocytes Bone Marrow Cells, Cultured Induced Pluripotent Stem Cells T-Lymphocytes, Cytotoxic Philadelphia Chromosome Multipotent Stem Cells CD4-Positive T-Lymphocytes Fetal Stem Cells Fetal Blood Killer Cells, Natural Lymphocytes T-Lymphocyte Subsets T-Lymphocytes, Regulatory Allografts Spermatogonia Neoplastic Stem Cells Blood Cells Plant Stems Dendritic Cells

Organisms9

Transplantation Chimera Cytomegalovirus Herpesvirus 6, Human Mice, Inbred C57BL Herpesvirus 4, Human Mice, Inbred BALB C Mice, SCID Radiation Chimera Chimera

Diseases47

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Myelodysplastic Syndromes Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Hepatic Veno-Occlusive Disease Acute Disease Primary Myelofibrosis Anemia, Aplastic Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Roseolovirus Infections Leukemia, Myeloid Lymphoproliferative Disorders Hodgkin Disease Lymphoma, Non-Hodgkin Infection Opportunistic Infections Stomatitis Leukemia, Lymphocytic, Chronic, B-Cell Adenoviridae Infections Chronic Disease Lymphoma Mycoses Epstein-Barr Virus Infections Blast Crisis Lymphoma, Follicular Aspergillosis Viremia Philadelphia Chromosome Neoplasm Recurrence, Local Neoplasms Disease Progression Severe Combined Immunodeficiency Postoperative Complications Lymphoma, Mantle-Cell Blood Group Incompatibility Disease Models, Animal Iron Overload Amyloidosis Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Chemicals and Drugs51

Myeloablative Agonists Busulfan Vidarabine Immunosuppressive Agents Minor Histocompatibility Antigens Antilymphocyte Serum Melphalan Cyclophosphamide HLA Antigens Antigens, CD34 Cytarabine Antibodies, Neoplasm Antineoplastic Agents Benzamides Fusion Proteins, bcr-abl Receptors, Purinergic P2X5 Pyrimidines Granulocyte Colony-Stimulating Factor Ganciclovir Piperazines Cyclosporine Antibodies, Monoclonal Etoposide Antibodies, Monoclonal, Murine-Derived Vincristine Benzydamine Antiviral Agents Antigens, CD Antibodies, Monoclonal, Humanized Stem Cell Factor Antigens, Viral Viral Matrix Proteins Carmustine DNA, Viral fms-Like Tyrosine Kinase 3 Antineoplastic Agents, Alkylating Thiotepa Biological Markers Cytokines Isoantigens Thalidomide Antigens, Neoplasm Tacrolimus Prednisone HLA-A2 Antigen Methotrexate Interferon-gamma Antifungal Agents Doxorubicin Protein Kinase Inhibitors Dexamethasone

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Treatment Outcome Bone Marrow Transplantation Remission Induction Histocompatibility Testing Lymphocyte Transfusion Retrospective Studies Combined Modality Therapy Cord Blood Stem Cell Transplantation Salvage Therapy Survival Analysis Disease-Free Survival Whole-Body Irradiation Survival Rate Liver Transplantation Lymphocyte Depletion Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Prognosis Kidney Transplantation Cell Transplantation Immunosuppression Prospective Studies Fatal Outcome Risk Factors Immunotherapy, Adoptive Heart Transplantation Leukocyte Transfusion Flow Cytometry Transplantation, Isogeneic Lymphocyte Count Immunotherapy Lung Transplantation Actuarial Analysis Cohort Studies Polymerase Chain Reaction Clinical Trials as Topic Incidence Cytogenetic Analysis Organ Transplantation Immunophenotyping Islets of Langerhans Transplantation Transplantation Kaplan-Meier Estimate Feasibility Studies Multivariate Analysis Cell Separation Pilot Projects Reverse Transcriptase Polymerase Chain Reaction Pancreas Transplantation Viral Load Predictive Value of Tests Drug Evaluation Leukapheresis Donor Selection Lymphocyte Activation Transplantation, Heterologous Bone Marrow Purging Cell Culture Techniques Skin Transplantation Life Tables Stem Cell Research Risk Assessment Fetal Tissue Transplantation Transplantation, Heterotopic Treatment Failure Cell- and Tissue-Based Therapy Disease Models, Animal Severity of Illness Index Case-Control Studies Blood Component Removal Lymphocyte Culture Test, Mixed Drug Administration Schedule Drug Therapy, Combination Platelet Transfusion Heart-Lung Transplantation

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes28

Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Virus Activation Histocompatibility Time Factors Chimerism Transplantation Immunology Immunocompromised Host Graft Rejection Cell Differentiation Lymphocyte Count Stem Cell Niche T-Cell Antigen Receptor Specificity Cell Proliferation Philadelphia Chromosome Hematopoiesis Cell Lineage Transplantation Tolerance Viral Load Cytotoxicity, Immunologic Lymphocyte Activation Regeneration Drug Resistance, Neoplasm Karyotype Radiation Chimera Graft vs Host Reaction Cell Survival

Disciplines and Occupations3

Hematology Outcome Assessment (Health Care)Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Siblings Living Donors Blood Donors Unrelated Donors

Health Care27

Treatment Outcome Retrospective Studies Survival Analysis Disease-Free Survival Survival Rate Follow-Up Studies Prospective Studies Fatal Outcome Risk Factors Actuarial Analysis Cohort Studies Clinical Trials as Topic Incidence Kaplan-Meier Estimate Feasibility Studies Multivariate Analysis Pilot Projects Predictive Value of Tests Donor Selection Outcome Assessment (Health Care)Life Tables Risk Assessment Treatment Failure Age Factors Severity of Illness Index Case-Control Studies Tissue and Organ Procurement

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Hematologic Neoplasms Transplantation Chimera Treatment Outcome Stem Cells Graft vs Leukemia Effect Bone Marrow Transplantation Myeloablative Agonists Tissue Donors Busulfan Remission Induction Recurrence Vidarabine Graft vs Tumor Effect Graft Survival Histocompatibility Testing Lymphocyte Transfusion Retrospective Studies Immunosuppressive Agents Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Combined Modality Therapy Siblings Cord Blood Stem Cell Transplantation Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Salvage Therapy Survival Analysis Hematopoietic Stem Cells Minor Histocompatibility Antigens Disease-Free Survival Whole-Body Irradiation Survival Rate Liver Transplantation Lymphocyte Depletion Antilymphocyte Serum Myelodysplastic Syndromes Virus Activation Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Histocompatibility Time Factors Melphalan Antineoplastic Combined Chemotherapy Protocols Chimerism Cyclophosphamide Hepatic Veno-Occlusive Disease Follow-Up Studies Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Cytomegalovirus Acute Disease T-Lymphocytes Prognosis Kidney Transplantation Primary Myelofibrosis Anemia, Aplastic Cell Transplantation HLA Antigens Hematologic Diseases Embryonic Stem Cells Leukemia, Myeloid, Accelerated Phase Antigens, CD34 Cytarabine Antibodies, Neoplasm Transplantation Immunology Immunosuppression Antineoplastic Agents Roseolovirus Infections Benzamides Adult Stem Cells Immunocompromised Host Leukemia, Myeloid Lymphoproliferative Disorders Fusion Proteins, bcr-abl Hodgkin Disease Receptors, Purinergic P2X5 Pyrimidines Graft Rejection Prospective Studies Nuclear Family Lymphoma, Non-Hodgkin Granulocyte Colony-Stimulating Factor Infection Fatal Outcome Ganciclovir Piperazines Cyclosporine Risk Factors Immunotherapy, Adoptive Heart Transplantation Opportunistic Infections Living Donors

No FAQ available that match "outcomes of patients regimen allogeneic stem cell transplantation"